Lifecore Biomedical, Inc.

Historical 13F Holders

Symbol
LFCR
CUSIP
514766104
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 514766104 since 12/18/2024, largest first.

Filer % of Class Filed
Legion Partners Asset Management, LLC 13D/A
17.3% 9/28/2026
Event 9/27/2026
Wynnefield Partners Small Cap Value, L.P. I 13D/A
14.3% 9/29/2026
Event 9/27/2026
22NW Fund, LP 13D/A
6.7% 7/2/2026
Event 6/30/2026
BlackRock, Inc. 13G 5.4% 7/29/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Greenhaven Road Investment Management, L.P. 13G/A
7.6%
Checked 5% or less
11/16/2026
Event 9/30/2026
David Capital Partners, LLC 13G/A
4.9% 2/5/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 106 25.4 M $167M
2026 Q2 101 25.4 M $133M
2026 Q1 107 25.1 M $112M
2025 Q4 105 24.8 M $226M
2025 Q3 101 24.3 M $199M
2025 Q2 89 24.7 M $221M
2025 Q1 89 24.5 M $190M
2024 Q4 79 24.8 M $203M
2024 Q3 84 20.7 M $117M
2024 Q2 78 20.4 M $120M
2024 Q1 82 21.6 M $115M
2023 Q4 80 21.3 M $132M
2023 Q3 71 19.8 M $132M
2023 Q2 80 19.9 M $174M
2023 Q1 84 22.7 M $81.7M
2022 Q4 94 24.7 M $160M
2022 Q3 87 24.7 M $220M
2022 Q2 91 25.3 M $252M
2022 Q1 99 25.7 M $279M
2021 Q4 100 25.9 M $287M
2021 Q3 94 25.5 M $235M
2021 Q2 96 25.8 M $290M
2021 Q1 94 26.0 M $275M
2020 Q4 97 26.5 M $288M
2020 Q3 97 27.3 M $265M
2020 Q2 96 26.8 M $213M
2020 Q1 89 27.1 M $235M
2019 Q4 94 27.1 M $306M
2019 Q3 105 26.5 M $288M
2019 Q2 100 27.5 M $258M
2019 Q1 92 26.3 M $323M
2018 Q4 90 25.9 M $306M
2018 Q3 91 25.7 M $368M
2018 Q2 92 25.1 M $374M
2018 Q1 89 26.3 M $343M
2017 Q4 91 25.8 M $325M
2017 Q3 97 25.8 M $334M
2017 Q2 96 25.3 M $376M
2017 Q1 86 25.1 M $301M
2016 Q4 93 24.7 M $340M
2016 Q3 93 25.0 M $336M
2016 Q2 96 25.7 M $277M
2016 Q1 95 25.1 M $263M
2015 Q4 109 24.3 M $287M
2015 Q3 111 24.0 M $280M
2015 Q2 107 24.4 M $353M
2015 Q1 101 24.2 M $339M
2014 Q4 109 24.3 M $335M
2014 Q3 106 24.6 M $299M
2014 Q2 100 24.1 M $302M
2014 Q1 98 23.7 M $265M